Hip Joint Injection

Hip Joint Injection

Procedure:  Hip Injection

Procedure in Detail:  The patient/family member has been informed of the risks and benefits of the planned procedure.  Informed consent was obtained.

In the fluoroscopy room, the patient was placed in a prone position and the skin over the left/right hip was prepped and draped in a sterile manner.  The hip joint was identified on fluoroscopy.  The skin and deeper tissues were numbed with 0.5% lidocaine.  Under fluoroscopic guidance a 3½ inch, 22 gauge spinal needle was advanced into the cavity of the hip joint.  The joint was injected with a mixture of 4 cc each of 1/8th Marcaine and 40 mg each of methylprednisolone.

The patient tolerated the procedure well.  The patient’s vital signs were monitored during the procedure.

Complications:

None.  Vital signs are stable during and after the procedure.

Full discharge instructions were given to the patient.  Patient was discharged in a stable condition.

Follow up:

I shall follow up in six weeks time to evaluate the progress.